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Abstract
Background: Extracellular activation of signal transduction pathways and their downstream target transcription factors (TFs)
are critical regulators of cellular processes and tissue development. The intracellular signaling network is complex, and
techniques that quantify the activities of numerous pathways and connect their activities to the resulting phenotype would
identify the signals and mechanisms regulating tissue development. The ability to investigate tissue development should
capture the dynamic pathway activity and requires an environment that supports cellular organization into structures that
mimic in vivo phenotypes. Taken together, our objective was to develop cellular arrays for dynamic, large-scale
quantification of TF activity as cells organized into spherical structures within 3D culture.
Methodology/Principal Findings: TF-specific and normalization reporter constructs were delivered in parallel to a cellular
array containing a well-established breast cancer cell line cultured in Matrigel. Bioluminescence imaging provided a rapid,
non-invasive, and sensitive method to quantify luciferase levels, and was applied repeatedly on each sample to monitor
dynamic activity. Arrays measuring 28 TFs identified up to 19 active, with 13 factors changing significantly over time.
Stimulation of cells with b-estradiol or activin A resulted in differential TF activity profiles evolving from initial stimulation of
the ligand. Many TFs changed as expected based on previous reports, yet arrays were able to replicate these results in a
single experiment. Additionally, arrays identified TFs that had not previously been linked with activin A.
Conclusions/Significance: This system provides a method for large-scale, non-invasive, and dynamic quantification of
signaling pathway activity as cells organize into structures. The arrays may find utility for investigating mechanisms
regulating normal and abnormal tissue growth, biomaterial design, or as a platform for screening therapeutics.
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Introduction
Signaling pathways provide communication from the extracel-
lular environment to direct cellular responses, and molecular
defects leading to aberrant pathway activity are associated with
many disease processes [1,2,3,4]. An extracellular stimulus, such as
a growth factor binding to a receptor, initiates a cascade of
reactions that may terminate in the activation of a transcription
factor (TF) that influences gene expression. At any moment, a cell
may experience multiple extracellular stimuli and these signals are
processed by the complex intracellular network to determine the
cellular response. The analysis of cellular responses to extracellular
stimuli is complicated by the interconnectedness of signaling
pathways, including cross-talk between pathways and redundancy
of pathway activity [5,6,7]. A technique for large-scale, quantita-
tive, and dynamic measurement of signaling pathway activity
would be an enabling tool to investigate normal and abnormal
cellular processes. Genomics and proteomics, the most common
large-scale techniques, report on specific mRNA or proteins levels,
and are not ideally suited to report pathway activity. Alternatively,
pathway activity can be quantified through TFs, for which
reporter constructs have been developed with consensus binding
sites that regulate production of a reporter gene. This goal of large-
scale analysis of TF activity has been performed through creation
of cell lines stably expressing TF reporters [8], yet a transfection-
based approach could be performed more quickly and extended to
a range of cell types. Transfection has been widely used to deliver
constructs that report on TF activity, though this transfection is
typically performed on a focused number of pathways.
The investigation of active pathways and cellular responses
performed within an environment where cells receive signals from
the extracellular matrix, neighboring cells, and soluble factors within
thelocalmilieuwould be aneffectivemeansofelucidatingregulatory
mechanisms. Natural and synthetic hydrogels are being employed to
mimic the in vivo environment by providing a three-dimensional (3D)
support for cells allowing the formation of multi-cellular structures
[9].Cellularresponsesinhydrogelscandiffersignificantlyfrommore
traditional2Dcellculture.Forexample,normalmammaryepithelial
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whereas breast cancer cells form structures with multiple degrees of
disorder[10],and thesephenotypesarenot observedon polystyrene.
Additionally, 3D culture leads to a differential response to growth
factors, hormones, extracellular matrix proteins, and chemotherapy
drugs [11,12]. Taken together, hydrogels for 3D culture that support
the formation of complex phenotypes provide valuable tools for
investigating the connection between the extracellular stimuli and
the cellular response.
We report a system for rapid, non-invasive, large-scale, dynamic
quantification of TF activity for cells growing in hydrogels. This
system is based on the parallel delivery of TF reporter constructs to
cells cultured within hydrogels in an array format. The TF
constructs encode for luciferase reporters, which are highly
sensitive and easily quantified to measure transcriptional activity.
Bioluminescence imaging can be employed to rapidly quantify
luciferase levels in a non-invasive manner [13] and can be
repeated to monitor pathway activity over time. While this system
is applicable for 2D culture, these assays are performed for cells
cultured in hydrogels to support and recreate the 3D environment
and the organization of multi-cellular structures. This system can
be a central technology to quantify activity of numerous TFs and
signaling pathways, which can provide a platform to screen
therapeutic compounds, identify pathways with aberrant activity
that could be targeted for therapy, or design environments that
promote specific cellular processes in regenerative medicine.
Results
Growth and transfection in hydrogels
Initial studies investigated transfection of MCF-7/WS8 cells
culturedinMatrigel.Thisnaturalmatrixhasbeenusedfornumerous
cell types [14], including MCF-7/WS8 cells, which are a well-
differentiated cancerous breast cancer cell line selected for estrogen
sensitivity [15]. Cells seeded inside Matrigel grew into multi-cellular
spheroids during the first three days of culture (Fig. 1A), a process not
perturbed by the presence of DNA lipoplexes (Fig. 1A). Enhanced
green fluorescent protein (EGFP) and Gaussia luciferase (GLuc)
reportervectorswereusedtocharacterizetransfection.Increasingthe
amount of DNA resulted in increased numbers of transfected cells
(Fig. 1B) and proteinproduction (Fig. 1C) after both time points. The
outputs of EGFP and GLuc were correlated (Fig. 1D), indicating that
GLuc was an appropriate measure for normalization of transfection
efficiency. All subsequent studies used 0.5 mg of DNA lipoplexes, as a
higher transfection efficiency was achieved.
Reporter constructs to quantify TF activity in hydrogels
Subsequent studies investigated the quantification of TF activity
for cells cultured in hydrogels using a dual-construct system: i) a
signal transduction reporter construct containing a TF binding site
that modifies the activity of a basal promoter to produce firefly
luciferase (FLuc), and ii) a normalization construct that contains a
constitutive promoter driving production of GLuc. Each well of the
array contained MCF-7/WS8 cells mixed with TF and normali-
zation construct lipoplexes and then encapsulated within Matrigel.
Initial studies employed three TF reporter vectors and one control
vector containing only a TATA box driving FLuc expression (TA).
AP1 regulates cell cycle progression and influences cell proliferation
and transformation [16]. ER is a steroid receptor that regulates
growth and apoptosis of cells and is a target of hormone therapy
[17]. p53 is a tumor suppressor protein that can induce apoptosis
upon DNA damage [18] and is involved in differentiation [19]. To
quantify TF activity after 48 h, GLuc was measured in culture
media and FLuc was measured from cell lysates. Normalized light
emission for each sample was determined by dividing the FLuc
reading by the GLuc reading and normalized TF activity was
determined by dividing the normalized light emission for each
sample by the averagenormalized light emission for the TA control.
Normalizing FLuc to GLuc was used to account for differences in
transfection efficiencyand cell numberand normalizationto theTA
control was applied to account for differences in TA promoter
activity and GLuc accumulation. All TFs produced light emission
that was significantly greater than the TA control (Fig. 2A),
demonstrating reporter constructs could quantify TF activity in
hydrogels. Activities were detected over multiple orders of
magnitude as well; AP1 and ER were both about 4-fold above
control and p53 was increased more than 100-fold.
Bioluminescence imaging was also used for rapid, non-invasive
quantification of TF activity for cells growing in Matrigel. Rather than
extracting and lysing cells, the substrate d-luciferin was added directly
to media and light production was quantified by imaging the three TF
reporters, the TA control, and non-transfected cells (NC) (Fig. 2B).
Luminescence from transfected cells was significantly greater than
background measured within non-transfected cells (Fig. 2C). Normal-
ized TF activities for all three TF reporters were greater than TA
(Fig. 2D), consistent with values from extracting and lysing cells.
Control studies involving the sequential replacement of GLuc and
FLuc vectors with a b-galactosidase vector did not affect either the
GLuc or bioluminescence readings (data not shown). Bioluminescence
imaging enabled rapid and non-invasive quantification of TF
activity within living cells cultured within hydrogels and output was
consistent with more standard extraction and lysis techniques.
TF activity in response to b-estradiol treatment
The system was subsequently evaluated for its ability to detect
changes in TF activity within Matrigel. Experiments were
performed in the absence and presence of b-estradiol (E2), which
was used to derive the MCF-7/WS8 cells. E2 signals by directly
binding ER, which translocates to the nucleus and binds DNA [20],
and also influences AP1 and p53 activities [21,22]. Cells were
treated with E2 or vehicle control for 24 hours prior to analysis, and
TF activity was determined with both cell lysis (Fig. 3A) and
bioluminescence imaging (Fig. 3B). In 3D culture, ER had a
significant increase with E2 treatment but AP1 and p53 did not
change with both techniques. The traditional approach of growing
cells on polystyrene (2D) resulted in significant increases in AP1,
ER, and p53 activities (Fig. 3C). Laminin, a major component of
Matrigel, reportedly decreases MCF-7 response to E2 [23] and may
account for differences between 2D and 3D culture. The dual-
reporter constructs could capture differential TF activity within
hydrogels with cell lysis as well as with bioluminescence imaging.
Large-scale 3D transfected cell arrays
Arrays were created and analyzed with bioluminescence
imaging to quantify 28 TFs (Fig. 4A) described in Table S1.
Eighteen normalized TF activities were significantly greater than
control: AP1, CRE, E2F1, ER, GAS, GATA4, HIF1, ISRE,
MEF3, NFAT, NFkB, p53, RAR, RXR, SP1, SRE, SRF and
VDR (Fig. 4B). Many of these TFs regulate cellular processes
involved in breast cancer [6,24,25] and are active in MCF-7 cells
[16,26,27,28]. Again, luminescence quantified activities over
multiple orders of magnitude. Replicates within arrays had low
variability (Fig. S1) and good correlation (R
2.0.96) (Fig. S2), with
weaker correlations across arrays (0.70,R
2,0.89). Data from the
same array clustered together by Euclidian distance of the mean
normalized activities (Fig. S3), suggesting blocking data by array
would be appropriate for statistical analyses. A few factors were
less active than TA, most noticeably STAT3. While TFs are able
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bioluminescence and produce values closer to background, and
our analysis most effectively identified those factors that produced
luminescence significantly greater than TA.
Dyamic TF activity in response to treatment
The 3D transfected cell arrays were subsequently employed for
large scale reporting on the dynamic changes in TF activity in
response to E2 treatment. Cells were treated with E2 or vehicle
control, and TF activity was quantified at 6, 24, and 48 h (Fig. 5A).
ER,HIF1,SP1,andSREallshowedsignificantchangesinactivityin
response to treatment (Fig. 5B). The increased ER activity mirrored
the response obtained with the small-scale array, and decreased
HIF1, SP1, and SRE activities at 24 h indicated that E2 reduced
induction. HIF1, IRF1, ISRE, NFkB, p53, and SP1 had activities
that increased with time and CRE, RAR, and SRF had activities
that decreased with time (Fig. 5B). These changes were consistent
with increased cell survival and inflammatory signaling associated
with cancerous growth [25,30] as well as decreased Rho and ERK
signaling associated with transferring cells to 3D culture [31,32].
Activin A treatment was also investigated to identify differential
TF profiles in response to another factor that influences cancer
Figure 1. Reporter constructs to normalize for transfection efficiency during structure formation in hydrogels. (A) MCF-7/WS8 cells
growing within Matrigel hydrogels without DNA complexes began as individual cells at day 1 (top left panel) and formed multi-cellular spheroids by
day 3 (top right panel), a process that was not inhibited by 0.5 mg DNA lipoplexes (bottom panel). Scale bar, 200 mm. (B–D) Cells were transfected
with reporter genes for EGFP and GLuc in parallel (0.5 or 0.05 mg DNA total with an pEGFP:pGLuc mass ratio of 9:1) within hydrogels. Percentage of
EGFP positive cells (B) and activity of GLuc (C) increased with DNA amount at both 24 and 48 h. Values are means 6 s.d. from two independent
experiments carried out in triplicate. GLuc activity correlated with %EGFP-positive cells (D).
doi:10.1371/journal.pone.0014026.g001
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via Smad signaling [33]. FLuc and GLuc were measured 6, 24,
and 48 h after treatment with activin A or vehicle. Heat map
representation of TF activity demonstrated dynamic activity of
numerous TFs (Fig. 6A) with significant differences (Fig. 6B).
Activin A induced early decreases in NFkB, p53, RXR, SP1, and
SRE activities, and later decreases in ISRE and SRF activities.
These changes are associated with decreased cell survival [30] and
increased differentiation [34]. Eight of the nine TFs that had
temporal changes in the E2 experiments had similar changes
following stimulation with activin A, yet five additional TFs had
significant changes: AP1, E2F1, ER, NFAT, and RXR. Of these
five TFs, AP1 was the only factor to change over time with vehicle
control. Using both E2 and activin A treatments, differential and
Figure 2. Dual-luciferase reporter constructs to measure TF activity. (A–D) MCF-7/WS8 cells within hydrogels were transfected in parallel
with pFLuc reporter constructs containing enhancer elements for specific TFs (AP1, ER, and p53), vector control (TA), or not transfected (NC). For wells
with reporter constructs, a constituently active pGLuc construct was delivered to normalize for transfection efficiency. (A) Cells were extracted and
lysed after 48 h to determine FLuc production, which was normalized to transfection efficiency. (B–D) Bioluminescence imaging was used to non-
invasively quantify FLuc production after 48 h from cells growing within Matrigel. (B) Pseudo-color mapping demonstrates localized luminescence
output from cells in hydrogels seeded in alternating wells of a 96-well plate. (C) Raw FLuc signals were significantly greater than bioluminescence
noise from NC. (D) FLuc signals from bioluminescence imaging were normalized to transfection efficiency and normalized TF activities for all three
factors were significantly greater than TA. Values are means 6 s.d. from at least three independent experiments carried out in triplicate.
doi:10.1371/journal.pone.0014026.g002
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arrays, demonstrating the system can capture widespread signaling
as cells organize into multi-cellular structures.
Discussion
Signal transduction pathways that terminate in TF activation
are non-linear, with cross-talk at multiple levels that affects activity
across pathways [5,6,7]. We report a method for rapid, dynamic,
and large-scale quantification of TF activity for cells cultured in
hydrogels that support cellular organization into multi-cellular
structures. This cellular array analyzed the activity of 28 TFs, and
at least 10 of the 28 TFs had activity that varied as a function of
time or biochemical stimulation. The implementation of biolumi-
nescence imaging for luciferase reporters is a direct measure of
transcriptional activity, which contrasts with the large-scale
genomics and proteomics approaches that are more typically
employed for pathway analysis [35,36]. These more standard
Figure 3. Dual-luciferase constructs to capture changes in TF activity in response to E2 treatment. (A,B) MCF-7/WS8 cells transfected with
pFLuc and pGLuc reporter constructs and seeded within Matrigel were treated with E2 for 24 h. TF activity was measured by extracting cells from
hydrogels and lysing (A) or by bioluminescence imaging (B). (C) MCF-7/WS8 cells were grown on 2D polystyrene, transfected, and treated with E2 for
24 h. TF activity was measured by lysing cells. Values are means 6 s.d. from at least three independent experiments carried out in triplicate. NS
indicates no significant difference with treatment.
doi:10.1371/journal.pone.0014026.g003
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implies its activity, yet they do not capture the impact of
phosphorylation state or cellular compartmentalization that are
common mechanisms for regulating pathway activity. Phosphor-
ylation, as in the MAP kinase pathway, is a common mechanism
to specifically regulate protein-protein interactions within the
pathway, and TF binding to DNA may depend on its
phosphorylation state [37]. Compartmentalization similarly regu-
lates molecular interactions by segregating the factors, which is
exemplified by steroid hormone receptors that are located outside
of the nucleus in their inactive state, yet contact with the ligand
leads to nuclear translocation and DNA binding [20,38]. The cell
arrays reported herein use living cells and thus maintain the
physiological context of the intracellular network; the production
of the reporter gene occurs only if the TF and all upstream
components in the pathway are present, located in the appropriate
cellular compartment, and have been post-translationally modified
to transmit the signal.
For our system reported herein, repeated measurement of the
sample allowed for longitudinal analysis of pathway activity during
the development of multi-cellular structures. Cellular signaling
networks are not stagnant, and signaling events can be transient or
cyclical [39,40]. Cellular responses are dependent on both the
specific TFs that are active and the timing of their activities
[41,42,43]. This TF activity array provides a large-scale view of
active pathways within a system at multiple time points. Signaling
pathway dynamics are typically captured on the time scale of
seconds to minutes to investigate the mechanistic interactions of
pathway components. This TF activity array focused on the time
scales relevant to the organization of cells into structures (i.e., hours
to days), and thus captured the net effect of the individual
interactions that sequentially activated pathways during tissue
formation or the cascade of pathways activated by an external
stimulus. Expressionresultingfrom transient transfection persists for
several days, with the decreasing expression the result of
degradation or silencing mechanisms. While techniques such as
stable transfection or infection could extend the duration of
expression, transient transfection results in substantial numbers of
plasmid copies within cell nuclei within hours [44], which enables
measurementofTFactivitysoonaftercellencapsulationforanalysis
of the early tissue development. Transient transfection can also be
performed more quickly than stable transfection and is more
amenable to scale-up. Using a well-established breast cancer cell
line, this array detected differential activities in processes associated
with the growth of cancer cells, such as cell survival (HIF1, NFkB),
proliferation (E2F1, ER, p53, RAR, RXR, SP1, SRE), differenti-
ation (p53, SP1), invasion (NFAT), hypoxia (HIF1), and inflamma-
tion(IRF1,ISRE,NFkB)[6,19,24,25,26,28,45,46]. ER, HIF1,SP1,
and SRE all showed significant responses to E2 treatment (Fig. 5).
ER activity increased, as expected, and the response persisted into
later time points. However HIF1, SP1, and SRE had decreased
activity relative to untreated cells only at 24 h, suggesting that E2
attenuated the activity of these factors at the early stages of culture.
For studies performed with activin A stimulation, SP1, SRE, NFkB,
RXR, and p53 had differential activity relative to vehicle at the
initial study time point (Fig. 6). Decreased activity of ISRE and SRF
was observed after the initial time point, suggesting these TFs
respond downstream of the initial stimulation. A dynamic response
of SP1, p53, and SRF in association with activin A and Smad
signaling has been described [47,48,49] whereas the responses of
SRE, NFkB, ISRE, and RXR have not been widely reported,
which illustrates the power of the array to simultaneously report on
known pathways and to identify unexpected connectivity of the
network. Taken together, the arrays provided a large-scale
identification of the cascade of signals occurring across multiple
days that drive the formation of multi-cellular structures.
Figure 4. Large-scale arrays to monitor TF signaling in parallel. (A) Pseudo-color mapping indicated localized luminescence from wells
throughout a portion of a 96-well plate randomly seeded with 16 conditions. (B) Quantification of TF activity at 24 h by bioluminescence imaging for
28 TFs. Values are means 6 s.d. from at least three independent experiments carried out in triplicate. NS indicates not significantly greater than the
TA control.
doi:10.1371/journal.pone.0014026.g004
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transduction pathway activity was analyzed within an environ-
mental context that allowed for cell-cell and cell-matrix interac-
tions that produced structures. Matrigel is often used to study the
growth of mammary epithelial cells with formation of either
normal (e.g. polarized) or cancerous (e.g. invasive) characteristics
that differs from the monolayer formation observed on 2D
polystyrene [50,51,52]. Morphological differences between 2D
and 3D are associated with differential signaling [11,53], including
differential response to E2 reported herein (Fig. 3) and decreased
Rho and ERK activities resulting from decreased focal adhesions
and tensional forces [31,32,54]. AP1, CRE, and SRE had
decreased activities over time and are downstream components
of the MAPK pathway [55,56,57], which is influenced by Rho and
ERK signaling [58]. Hence, our results are consistent with
decreased MAPK signaling for 3D relative to 2D culture. In
addition to differences in growth, cells within 3D matrices may
have an in vivo phenotypic response to chemotherapeutics [11,12],
further supporting the value of 3D culture for analysis of cellular
processes.
Bioluminescence imaging was instrumental in enabling large-
scale, dynamic, quantitative measurement of TF activity. Results
from bioluminescence imaging were consistent with the typical
approach of cell extraction and lysis, a labor-intensive process that
increased sample-to-sample variability. The normalization con-
struct accounted for spot-to-spot variability in transfection, a
variable that would otherwise hinder statistical analyses. Also,
normalizing to the TA control construct was important to account
for differences in transgene expression due to degradation and
silencing of the reporter plasmids. Luciferase reporters provided a
sensitive method due to enzymatic signal amplification, with
signals detected over several orders of magnitude [59]. Dynamic
analysis of TF activity in a single sample is more common with
fluorescent protein reporters [8], which can be quantified by plate
readers. The fluorescent reporters, however, lack signal amplifi-
cation and thus have more limited detection of weak signals.
Combining luciferase reporters with bioluminescence imaging
provided both sensitivity and dynamic analysis, and captured the
activity of numerous TFs simultaneously while minimizing the
number of samples and reagents.
Our 3D TF activity array profiled the activity of numerous
signaling pathways simultaneously as cells organized into struc-
tures and responded to biochemical stimuli. Bioluminescence
imaging was employed as a non-destructive technique capable of
repeated measurement that enabled dynamic activity to be
quantified. The array detected active TFs in at least 10 of the
Figure 5. Dynamic large-scale activities of TFs in response to E2 treatment. (A) TFs had variable activities as functions of treatment and time,
as indicated by a heat map representation of log2 transformation of the means. Vehicle control indicated by ‘2’ and E2 treatment indicated by ‘+’. (B)
TFs that had significant changes with treatment or time are presented on individual temporal plots, with log2 transformations of the TF activity
means plotted. Dashed lines indicate vehicle control and solid lines indicate E2 treated. Horizontal lines represent comparisons at different time
points for each condition, with 6 h to 24 h (top left), 24 h to 48 h (top right) and 6 h to 48 h (bottom). NS indicates no significant difference. A
significant difference with E2 treatment is indicated with the p-value at the significant time point. For example, CRE had significant differences in
activity between 6 and 24 h (P=4e-6) and between 6 and 48 h (P=1e-13) for untreated cells, and significant differences for all temporal comparisons
for E2 treated cells. ER had significantly greater activity at 24 and 48 h (P=0.007, P=0.013), but no significant differences with time. Values are log2
transformed means from at least three independent experiments carried out in duplicate for each condition.
doi:10.1371/journal.pone.0014026.g005
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and reproducible. Importantly, this activity was captured dynam-
ically, which identified pathways that were initially activated by a
biochemical stimulus, and those pathways whose activity was
altered subsequent to the initial stimulus. While the TF arrays
presented are applicable to 2D cultures as well, cellular behaviors
in 3D can be more relevant for recapitulating phenotypes observed
in vivo and provided the basis for establishing these 3D cell-based
arrays. This tool may be an enabling technology to identify
signaling events that are associated with normal and pathological
growth within the context of 3D microenvironments. The array
can be employed as a platform in numerous applications, such as
screening therapeutic compounds, identifying pathways with
aberrant activity that could be targeted for therapy, or designing




MCF-7/WS8 cells (provided by V. C. Jordan, Fox Chase
Cancer Center, Philadelphia, PA, USA) were maintained in
RPMI-1640 media supplemented with 10% fetal bovine serum
(FBS), 100 mM non-essential amino acids, 100 U antibiotic/
antimycotic, 2 mM L-glutamine (Invitrogen, Carlsbad, CA,
USA) and 6 ng/ml insulin (Sigma-Aldrich, St. Louis, MO,
USA), and cultured at 37uC and 5% CO2 in a humidified
incubator. For studies using E2 or activin A treatment, cells were
maintained in phenol red-free RPMI-1640 media with 10%
charcoal-stripped FBS (Invitrogen) for three days prior to seeding.
Plasmids
Plasmids were amplified with DH5a (Invitrogen), purified using
Qiagen (Valencia, CA, USA) reagents, and stored at 220uCi n
Tris-EDTA buffer solution (10 mM Tris, 1 mM EDTA, pH 7.4).
pEGFP encoded EGFP with a CMV promoter (Clontech,
Mountain View, CA, USA). pGLuc encoded GLuc with a CMV
promoter (New England Biolabs, Ipswich, MA, USA). pFLuc TF
reporter constructs encoded FLuc with a minimal TATA box from
the herpes simplex virus with one or multiple enhancer elements
upstream of the promoter that were specific for a particular TF
(Panomics, Fremont, CA, USA). pFLuc TF reporter constructs
were previously validated as described by the manufacturer [60].
Twenty-nine different pFLuc TF reporter plasmids were used: 28
for specific TFs and one that had no enhancer element and
reported basal FLuc expression (TA).
Figure 6. Dynamic large-scale activities of TFs in response to activin A treatment. (A) TFs had variable activities as functions of treatment
and time, as indicated by a heat map representation of log2 transformation of the means. Vehicle control indicated by ‘2’ and activin A treatment
indicated by ‘+’. (B) TFs that had significant changes with treatment or time are presented on individual temporal plots, with log2 transformations of
the TF activity means plotted. Dashed lines represent vehicle control and solid lines represent activin A treatment. Statistical comparisons are
described in legend of Figure 5. Values are log2 transformed means from at least three independent experiments carried out in duplicate for each
condition.
doi:10.1371/journal.pone.0014026.g006
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pFLuc TF reporter constructs, or pEGFP, and pGLuc (9:1 mg
pFLuc or pEGFP: mg pGLuc) were complexed with Transfast
(Promega, Madison, WI, USA) at a charge ratio of 0.5:1.0
Transfast:DNA in Opti-MEM (Invitrogen) and incubated for 10
minutes. MCF-7/WS8 cells were centrifuged, re-suspended with
DNA complexes,and incubated for 30 minutes.Cellsand complexes
were mixed with four times the volume of 4uCp h e n o lr e d - f r e e ,
growthfactor-reducedMatrigel(Trevigen,Gaithersburg,MD,USA)
and 50 mL of solution containing 50,000 cells and 0.5 mg total DNA
was deposited in black 96-well plates (Greiner Bio-One, Monroe,
NC, USA). Hydrogels were incubated at 37uC for 45 minutes and
fully supplemented RPMI-1640 media was subsequently added.
Arrays of hydrogels were constructed for simultaneous reporting
of TF activities. In parallel, lipoplex solutions with different pFLuc
TF reporter plasmids were made, added to cells, and combined
with precursor hydrogel solutions. A minimum of three hydrogels
for each condition was seeded in all experiments, except in the
longitudinal study in which hydrogels were seeded in duplicate.
For studies that report on 28 TFs, 15 or 16 reporter constructs in
triplicate were used at a time (14–15 TF reporters and 1 TA).
Experiments were independently performed at least three times.
For treatment studies, culturing media was replaced after 24 hours
of culture with media containing 10
210 ME 2 (Sigma-Aldrich) and
ethanol or 10 ng/ml activin A (gift of T. K. Woodruff, Northwestern
University, Evanston, IL, USA) and Tris. Stock solutions of 20 mM
E2 was made in 100% ethanol and stored at 220uCa n d7 5mg/mL
activin A made in 50 mM Tris and stored at 280uC.
Quantification of constituently active reporter genes
Transfection efficiency was determined by delivering pEGFP
followed by staining with Hoescht 33258 (Invitrogen) [61]. Total
numbers of fluorescent cells on each channel were counted using
ImageJ. Transgene expression with GLuc was determined with
20 mL of culture media, which was measured using a GLuc assay
kit (New England Biolabs) and luminometer (Turner Biosystems,
Sunnyvale, CA, USA).
Luminescence assays for FLuc activity
FLuc activity in cell lysates was quantified by extracting cells
from Matrigel using a 3D cell harvesting kit (Trevigen). Cell lysates
were frozen, defrosted, and subjected to a standard FLuc assay
(Promega) and a luminometer.
Bioluminescence imaging was performed with an IVIS imaging
system (Caliper, Hopkinton, MA, USA) as described previously
[13] with minor modifications. The substrate for FLuc, d-luciferin
(Caliper), was added to wells at 1 mM, incubated for 3 minutes
and then imaged for 1 minute. For longitudinal studies, hydrogels
were imaged, washed once with PBS, and then fresh media was
replaced. Normalized light emission was determined by dividing
the FLuc reading by the GLuc reading and normalized TF activity
was determined by dividing the normalized light emission for each
sample by the average normalized light emission for TA.
Statistics
Data were analyzed using R [62]. For the validation studies,
comparisons were performed using Welch t-tests and p-values were
adjusted with the false discovery reduction (FDR) technique [63] to
account for multiple comparisons (a=0.05, significant level). For
large-scale arrays, the package ‘limma’ [64] was used with base 2
logarithmic transformations on normalized data. Welch t-tests were
performed to comparetransformednormalized TF activity with TA
within the same array and a modified meta-analysis method [65]
was used to combine results from multiple arrays. Final p-values
wereadjusted with FDR (a=0.05).For dynamic array experiments,
normalized TF activities were base 2 logarithmic transformed and
arrays were considered independently from each other and
analyzed usinga ParametricalHierarchicalBayesian mode (PHBM)
[66] with empirical hierarchical hyperparameters [67] to compare
the effects of time and treatments on TF activities. The t-test results
from independent arrays were then combined by the modified
meta-analysis and adjusted by FDR as before. PHBM was also
employed to determine the similarity between experiments.
Supporting Information
Table S1 TF reporters used in large-scale transfected cell arrays.
Found at: doi:10.1371/journal.pone.0014026.s001 (0.05 MB
DOC)
Figure S1 Box plot of replicates from large-scale arrays. Means
of log2 transformed normalized TF activities from three replicates
across three arrays are shown. ‘1.1’ denotes array 1, replicate 1
and ‘2.3’ denotes array 2, replicate 3, etc. Means and standard
deviations were consistent within arrays, with some variability
between arrays. No outliers were present.
Found at: doi:10.1371/journal.pone.0014026.s002 (0.05 MB
DOC)
Figure S2 Pairwise comparisons of replicates from large-scale
arrays. Means of log2 transformed normalized TF activities from
three replicates across three arrays were compared. The correlation
factor is represented in the bottom right corner of each graph.
Comparisons within arrays showed good correlation (R
2.0.96),
and correlations across arrays were weaker (0.70,R
2,0.89).
Found at: doi:10.1371/journal.pone.0014026.s003 (0.11 MB
DOC)
Figure S3 Euclidian clustering of large-scale array data. Means
of log2 transformed normalized TF activities from three replicates
across three arrays were clustered. Data are denoted as described
in Fig. S1. Replicates within arrays clustered together, indicating
data could be blocked by array.
Found at: doi:10.1371/journal.pone.0014026.s004 (0.04 MB
DOC)
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